Furthermore, ASB2, MEIS2, and SRPX had significantly lower expression in high‐risk tumors compared to intermediate or low risk, suggesting these genes could be crucial indicators of PCa progression. This evidence concerns the gene ASB2 and posterior cortical atrophy.